Vivos Therapeutics Inc
NASDAQ:VVOS
Vivos Therapeutics Inc
NASDAQ:VVOS
Price:
2.07 USD
-1.43%
Market Closed
Updated:
May 29, 2024
Vivos Therapeutics Inc
Net Issuance of Common Stock
|
Vivos Therapeutics Inc
Net Issuance of Common Stock Peer Comparison
Comparables:
DVA
DGX
CVS
CI
LH
Competitive Net Issuance of Common Stock Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Vivos Therapeutics Inc
NASDAQ:VVOS
|
Net Issuance of Common Stock
$12m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
DaVita Inc
NYSE:DVA
|
Net Issuance of Common Stock
-$649.9m
|
CAGR 3-Years
24%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Net Issuance of Common Stock
-$216m
|
CAGR 3-Years
26%
|
CAGR 5-Years
2%
|
CAGR 10-Years
13%
|
|
|
CVS Health Corp
NYSE:CVS
|
Net Issuance of Common Stock
-$2.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
4%
|
|
|
Cigna Corp
NYSE:CI
|
Net Issuance of Common Stock
-$5B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-66%
|
CAGR 10-Years
-14%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Net Issuance of Common Stock
-$946.5m
|
CAGR 3-Years
-300%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-1%
|
See Also
What is Vivos Therapeutics Inc's Net Issuance of Common Stock?
Net Issuance of Common Stock
12m
USD
12m
USD
Based on the financial report for Dec 31, 2023, Vivos Therapeutics Inc's Net Issuance of Common Stock amounts to 12m USD.
What is Vivos Therapeutics Inc's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 5Y
17%
17%
The average annual Net Issuance of Common Stock growth rates for Vivos Therapeutics Inc have been -19% over the past three years , 17% over the past five years .
You don't have any saved screeners yet
